You have 9 free searches left this month | for more free features.

Condition

Chronic Inflammatory Demyelinating Polyneuropathy (1)

Generalized Myasthenia Gravis (1)

Graves Disease (1)

Overall Status

Recruiting (3)

Sign in for free

Phase

phase 2 (2)

phase 3 (1)

Sponsor

Immunovant Sciences GmbH (3)

Collaborator

Intervention

batoclimab 340 mg sc weekly (2)

batoclimab 340 mg sc bi-weekly (1)

batoclimab 680 mg sc weekly (1)

batoclimab 680 milligrams (mg) subcutaneous (sc) weekly (1)

imvt-1401 (batoclimab) (1)

matching placebo sc (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

Batoclimab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Graves Disease Trial in Mainz (IMVT-1401 (batoclimab))

Recruiting

Graves Disease

IMVT-1401 (batoclimab)

Mainz, Germany

Site Number - 6505

Jun 7, 2023

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Boca Raton, Austin (Batoclimab 680 milligrams (mg) subcutaneous (SC)

Recruiting

Chronic Inflammatory Demyelinating Polyneuropathy

Batoclimab 680 milligrams (mg) subcutaneous (SC) weekly
+2 more

Boca Raton, Florida
+1 more

Jan 31, 2023

Generalized Myasthenia Gravis Trial in Carlsbad (Batoclimab 680 mg SC weekly, Batoclimab 340 mg SC weekly, Matching Placebo SC)

Recruiting

Generalized Myasthenia Gravis

Batoclimab 680 mg SC weekly
+3 more

Carlsbad, California
+14 more

Jan 31, 2023